Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and Hematologic Neoplasms

vancomycin has been researched along with Hematologic Neoplasms in 61 studies

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (13.11)18.2507
2000's13 (21.31)29.6817
2010's30 (49.18)24.3611
2020's10 (16.39)2.80

Authors

AuthorsStudies
Akashi, K; Belabbas, T; Egashira, N; Hirota, T; Ieiri, I; Kato, K; Mori, Y; Suetsugu, K; Yamada, T1
Bouscary, D; Canouï, E; Charlier, C; Contejean, A; Fantin, B; Garcia-Vidal, C; Kernéis, S; Maillard, A; Parize, P1
Echizen, H; Goto, K; Takahashi, M; Tsuda, Y; Watanabe, F1
Hasegawa, H; Horino, T; Imai, M; Izumisawa, T; Kaneko, T; Soma, M; Takahashi, N; Wakui, N1
Margolis, E; Wolf, J1
Butler, AM; Ford, CD; Forsyth, S; Healy, R; Hoda, D; Jones, PB; Lopansri, BK; Majers, J; Snow, G; Webb, BJ1
Abu Ahmad, W; Amit, S; Averbuch, D; Friedman, G; Masarwa, R; Oster, Y; Stepensky, P; Temper, V1
Cao, P; Gao, LL; Li, SC; Nie, YM; Wang, J; Wang, Y; Wu, M; Xu, H; Ye, Q1
Abe, K; Goto, T; Ito, K; Kamio, S; Saito, K; Suzuki, N1
Fang, L; Gao, P; Hu, Y; Huang, L; Ni, Y; Wang, H; Wang, J; Yang, J; Zhang, L; Zhu, Z1
Dote, S; Horiuchi, N; Inose, R; Kobayashi, Y; Muraki, Y; Sazanami, K1
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N1
Burr, Z; Ford, C; Gazdik, M; Healy, R; Hoda, D; Lopansri, B; Majers, J; Petersen, FB; Webb, BJ1
Coombs, J; Ford, CD; Gazdik Stofer, MA; Lopansri, BK; Motyckova, G; Petersen, FB; Webb, BJ1
Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C1
Andre, N; Blin, O; Coze, C; Galambrun, C; Gallais, F; Guilhaumou, R; Marsot, A1
Fernández Lisón, LC; Malpartida Flores, M; Martín Rizo, L1
Banerjee, R; Esbenshade, AJ; Quach, HT; Zhao, Z1
Abidi, MZ; Bajrovic, V; Barber, GR; Benamu, E; Chase, S; Fish, DN; Gutman, JA; Kaiser, JN; Miller, MA; Morrisette, T; Mueller, SW; Tobin, J; Van Matre, AG1
Bhatt, V; Parmar, SR; Schuster, M; Yang, J; Zhang, Q1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SH; Kwon, JC; Lee, DG; Park, SH; Park, YJ; Yoo, JH1
Anca, D; Aydýn, D; Demirel, N; Gedik, H; Kanturk, A; Simsek, F; Yildirmak, T; Yokus, O1
Gea-Banacloche, J1
Jenkins, SG; Racanelli, AC; Satlin, MJ; Shore, TB; Soave, R; van Besien, K; Walsh, TJ1
Baruchel, A; Duquesne, F; Fahd, M; Fakhoury, M; Jacqz-Aigrain, E; Storme, T; Zhang, D; Zhao, W1
Hiramatsu, K; Itoh, H; Kadota, J; Kohno, K; Morinaga, Y; Ogata, M; Sato, Y; Suzuki, Y; Takano, K; Tokimatsu, I1
Maraki, S; Papadakis, IS1
Arıca, D; Aydın, D; Demirel, N; Gedik, H; Kantürk, A; Şimşek, F; Yıldırmak, T; Yokuş, O1
Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A1
Adams, B; Ford, CD; Gazdik, MA; Hoda, D; Lopansri, BK; Petersen, FB; Snow, GL; Webb, B1
Demir, AM; Kuloğlu, F; Ümit, EG1
André, N; Boulamery, A; Coze, C; Dupouey, J; Galambrun, C; Guilhaumou, R; Marsot, A; Simon, N1
Bangdiwala, A; Chong, PP; Gilligan, PH; Ivanova, A; Miller, WC; Shea, TC; van Duin, D; Weber, DJ1
Balasubramanian, N; Fox-Geiman, M; Kang Martinez, E; Parada, JP; Scardina, TL; Smith, SE1
Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L1
Dominguez-Gil, A; Fernández de Gatta, Mdel M; García, MJ; Sánchez Navarro, A; Santos Buelga, D1
Chung, D; Jakubowski, AA; Kamboj, M; Pamer, EG; Papanicolaou, G; Seo, SK; Sepkowitz, KA1
Bournakis, E; Christoulas, D; Dimopoulos, MA; Efstathiou, E; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kastritis, E; Kostis, E; Migkou, M; Papadimitriou, CA; Roussou, M; Terpos, E1
Berhoune, C; Bertrand, Y; Bleyzac, N; Zegbeh, H1
Ahlstrand, E; Persson, L; Söderquist, B; Svensson, K; Tidefelt, U1
Kimura, Y; Komatsu, T; Sudo, M1
de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K1
Billheimer, D; Calder, C; Frangoul, H; Manes, B; Tsiatis, AC; Wilkerson, KS1
D'Antonio, D; Di Bonaventura, G; Di Giovanni, P; Fiorilli, MP; Fioritoni, G; Francione, A; Manna, A; Parruti, G; Piccolomini, R; Romano, F; Rotolo, S; Savini, V; Schioppa, F; Staniscia, T1
Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N1
Andresen, S; Avery, R; Bolwell, B; Curtis, J; Kalaycio, M; Kosar, J; Kuczkowski, E; Mossad, S; Pohlman, B; Sands, K; Serafin, M; Shamp, J; Sobecks, R1
Buelga, DS; del Mar Fernandez de Gatta, M; Dominguez-Gil, A; García, MJ; Herrera, EV1
Ptushkin, VV1
Seymour, JF; Slavin, MA; Thursky, KA; Worth, LJ1
Graninger, W; Hirschl, AM; Kratzer, C; Presterl, E; Rabitsch, W1
Asano, S; Hongo, E; Kasahara, S; Kato, S; Konuma, T; Kurokawa, Y; Mae, H; Oiwa-Monna, M; Ooi, J; Takahashi, S; Tojo, A; Tomonari, A; Tsukada, N1
Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J1
Caballero, D; Calvo, MV; Domínguez-Gil, A; Fernández de Gatta, MD; Hernández, JM; San Miguel, JF1
Suppola, JP; Vaara, M; Valtonen, VV; Volin, L1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G1
Hatanaka, K; Hiraoka, A; Hosen, N; Karasuno, T; Kawamoto, S; Masaoka, T; Nakamura, H; Nakao, T; Teshima, H; Ujiie, H; Yagi, T1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P1
Bilgrami, S; Bona, RD; Chen, HH; Edwards, RL; Feingold, JM; Schindler, J; Tutschka, PJ1
Bouvet, A; Gerbal, R; Marie, JP; Ombandza-Moussa, E; Schlegel, L; Vekhoff, A1

Reviews

5 review(s) available for vancomycin and Hematologic Neoplasms

ArticleYear
Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:4

    Topics: Anti-Bacterial Agents; Hematologic Neoplasms; Humans; Neutropenia; Retrospective Studies; Vancomycin

2023
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
    The Journal of antimicrobial chemotherapy, 2023, 09-05, Volume: 78, Issue:9

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Febrile Neutropenia; Hematologic Neoplasms; Humans; Vancomycin

2023
Evidence-based approach to treatment of febrile neutropenia in hematologic malignancies.
    Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013

    Topics: Anti-Bacterial Agents; Antifungal Agents; Evidence-Based Medicine; Febrile Neutropenia; Hematologic Neoplasms; Humans; Infections; Mycoses; Risk Factors; Vancomycin

2013
Rothia mucilaginosa pneumonia: a literature review.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Hematologic Neoplasms; Humans; Immunocompetence; Immunocompromised Host; Lung; Male; Micrococcaceae; Middle Aged; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography; Vancomycin

2015
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance

2013

Trials

11 trial(s) available for vancomycin and Hematologic Neoplasms

ArticleYear
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:7

    Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin

2019
A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.
    Clinica chimica acta; international journal of clinical chemistry, 2015, Feb-02, Volume: 440

    Topics: Adult; Aged; Drug Monitoring; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; ROC Curve; Treatment Outcome; Vancomycin

2015
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin

2016
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
    American journal of hematology, 2010, Volume: 85, Issue:11

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Fever; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Length of Stay; Neutropenia; Survival Rate; Transplantation, Autologous; Vancomycin

2010
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
    Chemotherapy, 2004, Volume: 50, Issue:2

    Topics: Adult; Bacteremia; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Treatment Outcome; Vancomycin

2004
Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cost-Benefit Analysis; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Male; Middle Aged; Prospective Studies; Vancomycin

1996
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
[New quinolone versus vancomycin/tobramycin for intestinal sterilization in patients who undergo allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Intestines; Middle Aged; Quinolones; Sterilization; Tobramycin; Transplantation Conditioning; Vancomycin

1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin

1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin

1999
Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Catheterization, Central Venous; Child; Child, Preschool; Deglutition Disorders; Edema; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Male; Middle Aged; Ovarian Neoplasms; Pain; Phlebography; Thrombin Time; Thrombolytic Therapy; Transplantation, Autologous; Treatment Outcome; Ultrasonography, Doppler; Urokinase-Type Plasminogen Activator; Vancomycin; Venous Thrombosis

1999

Other Studies

45 other study(ies) available for vancomycin and Hematologic Neoplasms

ArticleYear
Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores.
    European journal of drug metabolism and pharmacokinetics, 2023, Volume: 48, Issue:6

    Topics: Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Organ Dysfunction Scores; Retrospective Studies; Sepsis; Vancomycin

2023
Augmented Renal Clearance of Vancomycin in Hematologic Malignancy Patients.
    Biological & pharmaceutical bulletin, 2019, Dec-01, Volume: 42, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Japan; Male; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Vancomycin

2019
Effect of Antimicrobial Stewardship on Outcomes in Patients With Cancer or Undergoing Hematopoietic Stem Cell Transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-14, Volume: 71, Issue:4

    Topics: Antimicrobial Stewardship; Carbapenems; Enterococcus; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Vancomycin

2020
Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-14, Volume: 71, Issue:4

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Vancomycin

2020
Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
    The Pediatric infectious disease journal, 2020, Volume: 39, Issue:4

    Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin; Vancomycin-Resistant Enterococci

2020
Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:9

    Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Computer Simulation; Drug Administration Schedule; Drug Elimination Routes; Febrile Neutropenia; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Treatment Outcome; Vancomycin

2020
A simple scoring method to predict augmented renal clearance in haematologic malignancies.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Critical Illness; Female; Hematologic Neoplasms; Humans; Japan; Kidney Function Tests; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Vancomycin

2020
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
    Pharmacotherapy, 2020, Volume: 40, Issue:12

    Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Asian People; Child; Child Health Services; Child, Preschool; China; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Infant; Infusions, Intravenous; Male; Retrospective Studies; Vancomycin

2020
Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration.
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:6

    Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2021
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Le infezioni in medicina, 2017, Mar-01, Volume: 25, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin

2017
Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-15, Volume: 64, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Cohort Studies; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci

2017
Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
    Infection control and hospital epidemiology, 2017, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Equipment Contamination; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Humans; Infection Control; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Patients' Rooms; Proportional Hazards Models; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult

2017
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Medecine et maladies infectieuses, 2017, Volume: 47, Issue:8

    Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin

2017
Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
    Paediatric drugs, 2018, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Child, Preschool; Drug Dosage Calculations; Drug Monitoring; Emollients; Female; Hematologic Neoplasms; Humans; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin

2018
Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients.
    Medicina clinica, 2019, 10-11, Volume: 153, Issue:7

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colonic Neoplasms; Diarrhea; Female; Fidaxomicin; Hematologic Neoplasms; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin

2019
Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:10

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vancomycin

2019
A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Endpoint Determination; Enterocolitis, Pseudomembranous; Female; Hematologic Neoplasms; Humans; Incidence; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin

2014
Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    BMC infectious diseases, 2013, Oct-29, Volume: 13

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vancomycin; Vancomycin Resistance

2013
The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
    African health sciences, 2013, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enterococcus; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Vancomycin; Young Adult

2013
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:12

    Topics: Adult; Bacteremia; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Neutropenia; Prognosis; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci

2014
Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Computer Simulation; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Infant; Male; Models, Statistical; Precision Medicine; Vancomycin

2014
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
    African health sciences, 2014, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colony Count, Microbial; Cost-Benefit Analysis; Cross Infection; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Mass Screening; Middle Aged; Neutropenia; Retrospective Studies; Turkey; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult

2014
Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.
    American journal of infection control, 2016, 10-01, Volume: 44, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Intensive Care Units; Male; Middle Aged; Patients' Rooms; Vancomycin; Vancomycin Resistance; Young Adult

2016
Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2017, Mar-01, Volume: 34, Issue:1

    Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Febrile Neutropenia; Female; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Length of Stay; Leukemia; Logistic Models; Male; Middle Aged; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult

2017
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:5

    Topics: Anti-Bacterial Agents; Child; Cyclosporine; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin

2016
Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Clinical therapeutics, 2016, Volume: 38, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Enterococcus faecium; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Vancomycin; Vancomycin Resistance

2016
Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Pharmacotherapy, 2017, Volume: 37, Issue:4

    Topics: Academic Medical Centers; Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Transplantation Conditioning; Vancomycin

2017
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin

2009
Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/pharmacodynamic analysis.
    Clinical pharmacokinetics, 2009, Volume: 48, Issue:4

    Topics: Anti-Bacterial Agents; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Models, Statistical; Monte Carlo Method; Staphylococcus; Vancomycin

2009
The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Aged; Bacteremia; Drug Resistance, Bacterial; Enterococcus; Female; Gastrointestinal Tract; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Depletion; Male; Middle Aged; Retrospective Studies; Risk Factors; T-Lymphocytes; Time Factors; Vancomycin; Young Adult

2010
[Vancomycin: what dosages are needed to achieve efficacy in paediatric hematology/oncology?].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18, Issue:8

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Dosage Calculations; Hematologic Neoplasms; Humans; Infant; Retrospective Studies; Vancomycin

2011
Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Anti-Bacterial Agents; Bacteremia; Coagulase; Drug Resistance, Microbial; Glycopeptides; Hematologic Neoplasms; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Retrospective Studies; Species Specificity; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Sweden; Teicoplanin; Vancomycin

2011
[Use of the critical path with the electronic chart system using meropenem, vancomycin, liposome amphotericin B for the febrile neutropenia].
    The Japanese journal of antibiotics, 2011, Volume: 64, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Critical Pathways; Drug Therapy, Combination; Electronic Health Records; Female; Fever; Hematologic Neoplasms; Humans; Liposomes; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins; Treatment Outcome; Vancomycin; Young Adult

2011
Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
    Bone marrow transplantation, 2004, Volume: 33, Issue:9

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Infant; Infection Control; Male; Neoplasms; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin Resistance

2004
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2004, Volume: 54, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin

2004
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
    Bone marrow transplantation, 2005, Volume: 35, Issue:5

    Topics: Bacteremia; Bone Marrow Transplantation; Cause of Death; Disease Progression; Drug Resistance; Enterococcus faecalis; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Homologous; Vancomycin

2005
Population pharmacokinetic analysis of vancomycin in patients with hematological malignancies.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Drug Monitoring; Hematologic Neoplasms; Humans; Middle Aged; Models, Biological; Vancomycin

2005
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:6

    Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin

2006
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk.
    European journal of haematology, 2007, Volume: 79, Issue:3

    Topics: Acute Disease; Adult; Aged; Case-Control Studies; Disease Outbreaks; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin; Vancomycin Resistance

2007
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    European journal of haematology, 2007, Volume: 79, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Coagulase; Daptomycin; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Hematologic Neoplasms; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin

2007
Early renal injury after myeloablative cord blood transplantation in adults.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Adult; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vancomycin; Whole-Body Irradiation

2008
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
    The Journal of infection, 2008, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria

2008
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4

    Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

1996
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
    Pathologie-biologie, 1998, Volume: 46, Issue:6

    Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin

1998
[Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
    Pathologie-biologie, 2002, Volume: 50, Issue:3

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Critical Care; Cross Infection; Drug Resistance; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Lactams; Male; Middle Aged; Mouth; Neutropenia; Opportunistic Infections; Pneumococcal Infections; Respiratory Distress Syndrome; Shock, Septic; Species Specificity; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus sanguis; Treatment Outcome; Vancomycin

2002